You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
BACK TO ALL NEWS/

27-06-2017

Cash Tender Offer for Notes due 24 April 2019

Released: 27/06/2017 – 12:19
RNS Number: 3112J
Kedrion S.p.A.
27th   June 2017

 

Kedrion S.p.A. (the “Company”) announced that it has invited holders of its outstanding € 300,000,000 in aggregate principal amount 4.625 per cent. Notes due 24 April 2019 to tender their Notes for purchase by the Company for cash.

The Offer is subject to the terms and conditions set forth in a tender offer memorandum dated 27 June 2017.

The company has also announced its intention to issue a series of new euro-denominated notes.

The Purchase Price for Notes validly tendered and accepted for purchase will be a fixed purchase price of 107% of the principal amount of each Note accepted by the Company for purchase pursuant to the Offer (being €1,070 per €1,000 in principal amount of such Notes).

The launch notice has been published on the ISE website: http://www.ise.ie/app/announcementDetails.aspx?ID=13274770

 

Disclaimer

Not for distribution in or into or to any person located or resident in the United States, its territories and possessions, any state of the United States or the district of Columbia or in or into or to any person located or resident in any other jurisdiction where it is unlawful to distribute this document (see “Offer and distribution restrictions” in the tender offer memorandum). persons into whose possession this announcement and/or the tender offer memorandum comes are required by each of the company, the joint dealer managers and the tender agent to inform themselves about, and to observe, any such restrictions. neither this announcement nor the tender offer memorandum constitutes an invitation to participate in the offer in any jurisdiction (including, specifically the United States) in which, or to any person to or from whom, it is unlawful to make such invitation. any purported tender of notes in the offer resulting directly or indirectly from a violation of these restrictions will be invalid and any purported tender of notes made by a person located in the United States or any agent, fiduciary or other intermediary acting on a non-discretionary basis for a principal giving instructions from within the united states will be invalid and will not be accepted.

 

For more information please contact: investor@kedrion.com